Furthermore, cells in HER2-positive breast cancer often exhibit a high proliferation rate and a low apoptosis rate, this means that tumor cells can rapidly grow and spread, while being difficult to eliminate through natural apoptosis processes [3, 4]. This evidence concerns the gene ERBB2 and breast carcinoma.